Welcome to Exaeris.

 

At Exaeris, creating access to innovative medicines is our first order of business. Exaeris, Inc. is a specialty pharmaceutical sales and marketing company focused on improving therapeutic outcomes by delivering valued products and services to patients and physicians. A wholly owned subsidiary of Inyx, Inc., Exaeris capitalizes on Inyx’s drug delivery technologies, development platforms, and strategic global relationships to advance medical science for patients and maximize value for our partners and stakeholders.